|
JAMA Network Open |
Administration of AntiSARS-CoV-2 Monoclonal Antibodies After US Food and Drug Administration Deauthorization |
1 |
Yes |
9/2/2025 |
|
JAMA Dermatology |
Administrative Burden and Costs of Prior Authorizations in a Dermatology Department |
1 |
Yes |
5/20/2025 |
|
Louisiana Medical Mutual Insurance Company (LAMMICO) |
Adult ADHD for Primary Care |
1 |
Yes |
1/12/2025 |
|
JAMA Cardiology |
Adult With Unrepaired Single-Ventricle Defect |
1 |
Yes |
9/6/2026 |
|
American Association for Physician Leadership |
Advanced Financial Decision Making |
7.0 |
Yes |
3/31/2026 |
|
American Medical Association |
Advanced Rooming and Discharge - Optimize Team-Based Visit Workflows |
0.5 |
Yes |
4/24/2025 |
|
American Medical Association |
Advancing Equity Through Quality and Safety During COVID-19 |
0.5 |
Yes |
5/5/2025 |
|
American Medical Association |
Advancing Equity Through Quality and Safety During COVID-19 |
0.5 |
Yes |
5/5/2025 |
|
American Medical Association |
Advancing Equity Through Quality and Safety Peer Network |
0.75 |
Yes |
12/8/2024 |
|
American Medical Association |
Advancing Equity Through Quality and Safety: Five Focus Areas |
0.25 |
Yes |
11/12/2027 |
|
JAMA Network Open |
Advancing Health Disparities Science Through Social Epigenomics Research |
1 |
Yes |
7/29/2027 |
|
AMA Journal of Ethics |
Advancing Health Equity by Avoiding Judgmentalism and Contextualizing Care |
1 |
Yes |
1/23/2027 |
|
JAMA Health Forum |
Advancing Health Policy and Outcomes for People With Intellectual or Developmental Disabilities - A Community-Led Agenda |
1 |
Yes |
8/2/2027 |
|
Massachusetts Medical Society |
Advocating for Appropriate Medical Assessments for People with Intellectual and Developmental Disabilities |
1 |
Yes |
5/25/2025 |
|
JAMA |
Age-Related Macular Degeneration - A Review |
1 |
Yes |
1/9/2027 |
|
JAMA Network Open |
Age-Varying Susceptibility to the Delta Variant (B.1.617.2) of SARS-CoV-2 |
1 |
Yes |
3/18/2025 |
|
American Medical Association |
AI and Precision Health |
0.75 |
Yes |
7/9/2027 |
|
American Medical Association |
AI for Prognostication and Treatment |
0.5 |
Yes |
2/20/2027 |
|
Louisiana Medical Mutual Insurance Company (LAMMICO) |
AI in Medicine: Cutting-Edge or Legal Landmine |
1 |
Yes |
9/22/2027 |
|
JAMA Oncology |
Aiming at a Tailored Cure for ERBB2-Positive Metastatic Breast CancerA Review |
1 |
Yes |
4/21/2025 |
